Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
Sagittal spinopelvic alignment in the Standing and Prone positions of patients with old traumatic thoracolumbar kyphosis: relationship with immediately postoperative parameters
I also bought kettle bells, joined an online gym, and walked for hours, but the pounds kept coming
Managing Potential Side Effects: Your provider can offer guidance on common side effects such as nausea, vomiting, or changes in appetite
After that, additional manufacturers gradually entered the market with their own versions, increasing supply over time